Clinical Trial Update: IFN-α in Relapse Prevention. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating interferon alpha for relapse prevention in acute myeloid leukemia and myelodysplastic syndromes; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: NOT_YET_RECRUITING